Cross-strait Tsinghua Research Institute

The Institute was co-founded by the Xiamen Municipal Government, Beijing Tsinghua University, and the Hsinchu Tsinghua University alumni network in April 2015. It has not disclosed specific named investment committee members or principals publicly. Governance appears distributed across the three founding parties, with operational leadership embedded in its research platforms and centers.

No. It functions as a technology-transfer and incubation platform, building research centers and laboratories that develop intellectual property and spin out commercial ventures. It does not raise closed-end blind pools or report partner-level carried interest structures. Its investment vehicle is effectively the innovation platform model, turning academic IP into companies rather than committing capital as a traditional LP or GP.

Its mandate spans early stage, seed, start-up, and expansion-stage ventures. The innovation platforms are structured to support teams from laboratory prototype through initial commercialization, though it has not published a specific graduation criterion or follow-on fund allocation.

Three innovation platforms define the focus: medical engineering, including biophotonics, laser medicine, AI-driven diagnostics, and medical nutrition; cross-strait new energy, encompassing environmental systems and industrial energy storage; and digital China, covering big data and information infrastructure.

Yes. The inclusion of Hsinchu Tsinghua University alumni as a founding party formally links the Taiwan-based campus of Tsinghua into the governance and likely the talent pipeline. This cross-strait architecture is the Institute's core differentiator, channeling IP and researchers from both sides of the Taiwan Strait into Xiamen-based commercialization.